Insights

Scale and Reach Bachem is a mid-to-large cap manufacturer with global operations and a revenue base in the 250-500 million range, indicating a strong platform for expanding contract manufacturing and collaborative development services worldwide.

Peptide and Oligo Focus Specialization in peptides and oligonucleotides presents a clear cross-sell opportunity for related biologics services, analytical development, and supply chain solutions to pharmaceutical and biotech customers expanding in these modalities.

Innovation-Driven Longstanding expertise and an innovation-first stance suggest partnerships for advanced manufacturing, process optimization, and scale-up programs that could attract CRO/CMO clients seeking reliable technology transfer and GMP-ready production.

Global Footprint International presence across Europe, the US, and Asia enables multi-region supply strategies and co-development initiatives, appealing to customers seeking geographic redundancy, regional regulatory support, and global clinical trials.

Digital and Ops Readiness Adoption of modern tech stack (Azure, Salesforce, DocuSign, Ansible) implies potential for streamlined procurement, contract management, and customer onboarding automation to shorten sales cycles and improve customer experience.

Similar companies to Bachem

Bachem Tech Stack

Bachem uses 8 technology products and services including Ansible, Salesforce, UKG, and more. Explore Bachem's tech stack below.

Bachem's Email Address Formats

Bachem uses at least 3 email formats:
Bachem Email FormatsExamplePercentage
First.Last@bachem.comJohn.Doe@bachem.com
95%
Last.First@bachem.comDoe.John@bachem.com
4%
First@bachem.comJohn@bachem.com
1%

Frequently Asked Questions

What is Bachem's phone number?

Minus sign iconPlus sign icon
You can contact Bachem's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bachem's stock symbol?

Minus sign iconPlus sign icon
Bachem is a publicly traded company; the company's stock symbol is 0QND.L.

How much revenue does Bachem generate?

Minus sign iconPlus sign icon
As of August 2026, Bachem's annual revenue is estimated to be $250M - $500M.

What is Bachem's SIC code and NAICS code?

Minus sign iconPlus sign icon
Bachem's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bachem have currently?

Minus sign iconPlus sign icon
As of August 2026, Bachem has approximately 2.1K employees across 4 continents, including Europe, North America and Asia. Key team members include Coo Office Lead: R. H., Chief Commercial Officer / Member Of The Corporate Executive Committee: T. W. and Chief Human Resources Officer: V. B. M. Explore Bachem's employee directory with LeadIQ.

What industry does Bachem belong to?

Minus sign iconPlus sign icon
Bachem operates in the Pharmaceutical Manufacturing industry.

What technology does Bachem use?

Minus sign iconPlus sign icon
Bachem's tech stack includes Ansible, Salesforce, UKG, Salesforce Marketing Cloud Account Engagement, DocuSign, Wistia, Microsoft Azure and VMware.

What is Bachem's email format?

Minus sign iconPlus sign icon
Bachem's email format typically follows the pattern of First.Last@bachem.com. Find more Bachem email formats with LeadIQ.

How much funding has Bachem raised to date?

Minus sign iconPlus sign icon
As of August 2026, Bachem has raised $637M in funding. The last funding round occurred on Apr 27, 2026.

When was Bachem founded?

Minus sign iconPlus sign icon
Bachem was founded in 1971.
Bachem logo

Bachem

Pharmaceutical ManufacturingBasel-Landschaft, Switzerland1001-5000 Employees

Bachem is a Swiss-based, public pharmaceutical manufacturer focused on the development and production of peptides and oligonucleotides. With more than five decades of experience, the company provides products for research, clinical development, and commercial applications to pharmaceutical and biotechnology customers worldwide and offers a comprehensive range of services. The organization operates internationally, with its headquarters in Switzerland and locations in Europe, the United States, and Asia. Its address is 144 Hauptstrasse Bubendorf, Basel-landschaft, Switzerland. The company employs between 1,001 and 5,000 people.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
0QND.L
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1971
Employees
1001-5000

Section iconFunding & Financials

  • $637M

    Bachem has raised a total of $637M of funding over 1 rounds. Their latest funding round was raised on Apr 27, 2026 as a Post IPO Debt.

  • $250M - $500M

    Bachem's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.